The SM047 antibody is an IgM monoclonal antibody that was developed by McCluggage's group at the UK Royal Group of Hospitals and recognizes a multivalent antigen from ovarian carcinoma (OvC) cells (1). Early studies indicate that the epitope is specifically expressed in the adenocarcinoma glycocalyx, and is most strongly expressed in serous OvC subtypes.
Glandular tissues synthesise substances for release, such as hormones and enzymes. The term adenocarcinoma is used to describe a cancer that originates within a glandular tissue, for example the ovary.
